MarketBeat Earnings
News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 1–36
- Matches
- 27047
- Sources here
- 17
- Companies here
- 41
Active search
27047 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
AI video startup Higgsfield hits $5.4B valuation with Goldman, Intel backing: FT
[AI Artificial Intelligence concept. Media concept TV - video wall with small screens. . Digital multiple television screens.] Vertigo3d AI video generator Higgsfield AI raised $400M at a $5.4B valuation, according to the _Financial Times. _ Major backers include Goldman Sachs (GS [https://seekingalpha.com/symbol/GS]), Intel …
Goldman Says Markets Too Hawkish on Betting Fed Will Hike Rates
Goldman Sachs believes that market expectations for Federal Reserve interest rate hikes are overly aggressive. The firm's chief economist, Jan Hatzius, indicated that a rate increase in September is highly improbable due to recent softer retail sales, disappointing employment figures, and cooling inflation. This …
Amazon, Alphabet, and Microsoft Are Dropping Nearly $600 Billion on Capital Expenditures: 1 Clear Winner Emerges
Amazon (NASDAQ: AMZN), Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL), and Microsoft (NASDAQ: MSFT) are the world's three biggest cloud computing providers. They are spending a ton of money on adding more computing capacity this year, with Amazon leading the way, on track to spend $220 …
Walmart, Target, Home Depot, Fed Minutes, and More to Watch This Week
Lowe’s, TJX, Alibaba, and Toll Brothers will also report earnings. On the economic front, we’ll see Fed minutes, housing-market data, and readings on manufacturing and services activity. Continue Reading
Vanda Prepares BYSANTI Launch As Patent Protection Extends To 2044
Vanda Pharmaceuticals is set to launch BYSANTI in the second half of 2026 following FDA approval for bipolar I disorder and schizophrenia, with patent protection extending until May 2044. The company also reported strong Q2 Fanapt sales growth and has several late-stage pipeline readouts …
Soup kit sold at Pennsylvania Walmart stores recalled over possible Listeria contamination
Kettle Cuisine LLC has recalled its Marketside Tomato Bisque Soup Kit due to potential Listeria monocytogenes contamination. The recalled kits were sold at Walmart stores, including those in Pennsylvania, between June 30 and July 7, and have a use-by date of August 22. Consumers …
Applied Materials Trades More Than 25% Below Its High With Revenue at a Record
Applied Materials (NASDAQ: AMAT) came into Thursday's fiscal third-quarter report about 28% beneath its 52-week high of $739.67, closing the session at $534.54. The chip-equipment maker then posted records on nearly every line. Revenue came in at $9.1 billion, up 25% year over year. …
PubMatic CEO Rajeev Goel sells $3.75 million in company stock
PubMatic CEO Rajeev Goel sold 211,302 shares of company stock for approximately $3.75 million at an average price of $17.7444 per share. These transactions were executed under a Rule 10b5-1 trading plan and occurred after Goel exercised options to acquire an equal number of …
Walmart tomato bisque soup recalled over possible Listeria contamination
Kettle Cuisine LLC is recalling over 3,000 Marketside Tomato Bisque Soup Kits sold at select Walmart stores due to potential Listeria contamination. The recall affects kits with UPC 194346474004 and a use-by date of August 22, 2026, distributed in 29 states between June 30 …
Why Tarsus Pharmaceuticals (TARS) Is Up 6.8% After Raising XDEMVY 2026 Sales Guidance - And What's Next
Tarsus Pharmaceuticals (TARS) saw its stock rise by 6.8% after reporting strong second-quarter 2026 results and raising its 2026 XDEMVY net product sales guidance to US$685 million–US$705 million. This increase signals management's confidence in XDEMVY's commercial trajectory, though the company still faces risks associated …
Ascendis Pharma A/S Just Recorded A 104% EPS Beat: Here's What Analysts Are Forecasting Next
Ascendis Pharma A/S reported strong Q2 results, with revenues beating expectations by 2.8% and statutory profit exceeding forecasts by 104%. Analysts have subsequently upgraded their EPS estimates for 2026, though the consensus price target remains unchanged at US$310. The company is expected to continue …
Walmart Inc. stock Analysis: Key Resistance Before Earnings
Walmart Inc. stock is at a critical technical juncture, trading in a tight range just days before its fiscal second-quarter earnings report on August 20. The stock is facing key resistance at the 200-day EMA around $116, while shorter-term momentum shows a bullish lean …